Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BioIncyte PRFM
- Development stage
- Unknown
- Lead developer
- Royal Biologics
- Modality
- Cell Therapies
- Administration
- Injection
01
Overview
BioIncyte PRFM is a next-generation autologous platelet-rich fibrin matrix (PRFM) system developed by Royal Biologics. Commercially launched in February 2023, the system is a medical device that utilizes a single-spin, closed-loop centrifuge process to convert a patient's own blood into an ultra-pure PRFM, specifically designed to eliminate red and white blood cell contamination. The resulting biologic consists of platelets and growth factors embedded within a fibrin matrix scaffold, which facilitates a sustained-release environment. This allows for the prolonged release of growth factors, stem cell migration, and regenerative signaling at the injection site over several days, significantly exceeding the duration of traditional platelet-rich plasma (PRP). It is primarily utilized in orthopedic, sports medicine, regenerative medicine, and aesthetic applications.
- Brand names
- BioIncyte PRFM
- Other names
- BioIncyte
Beyond the preview
Go deeper on BioIncyte PRFM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioIncyte PRFM.